Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by VancouverPigon Nov 13, 2017 2:12pm

99 Views

Post# 26953051

RE:RE:RE:RE:RE:RE:Valeant Completes Sale of Obagi Medical Products

Waxie. I should be running this steaming pile of rotting stock certificates for sure.

When I take over after the aGM, My plan would be to have investors sell out all the dead stock, pool all their money and invest it in a weed farm. Yup, A Weed farm. If we need to raise some money, we could do a new PP (Pot Placement). The takers of the Pot Placement would have to option to convert it to a monthly dividend of a ounze of weed per share. That way, as the stock price got higher, so could they.

Signed: Vancouver the PotPig.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages